Larkin J - Search Results

1

Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma.

Lee CH, Motzer RJ, Glen H, Michaelson MD, Larkin J, Minoshima Y, Kanekiyo M, Ikezawa H, Sachdev P, Dutcus CE, Funahashi Y, Voss MH. Lee CH, et al. Among authors: larkin j. Br J Cancer. 2021 Jan;124(1):237-246. doi: 10.1038/s41416-020-01092-0. Epub 2020 Oct 7. Br J Cancer. 2021. PMID: 33024271 Free PMC article. Clinical Trial.

2

Kinase inhibitors in the treatment of renal cell carcinoma.

Larkin JM, Eisen T. Larkin JM, et al. Crit Rev Oncol Hematol. 2006 Dec;60(3):216-26. doi: 10.1016/j.critrevonc.2006.06.008. Epub 2006 Jul 24. Crit Rev Oncol Hematol. 2006. PMID: 16860997 Review.

3

A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.

Larkin JM, Hughes SA, Beirne DA, Patel PM, Gibbens IM, Bate SC, Thomas K, Eisen TG, Gore ME. Larkin JM, et al. Br J Cancer. 2007 Jan 15;96(1):44-8. doi: 10.1038/sj.bjc.6603503. Epub 2006 Dec 5. Br J Cancer. 2007. PMID: 17146474 Free PMC article. Clinical Trial.

4

Drug insight: advances in renal cell carcinoma and the role of targeted therapies.

Larkin JM, Chowdhury S, Gore ME. Larkin JM, et al. Nat Clin Pract Oncol. 2007 Aug;4(8):470-9. doi: 10.1038/ncponc0901. Nat Clin Pract Oncol. 2007. PMID: 17657252 Review.

5

Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies.

Chowdhury S, Larkin JM, Gore ME. Chowdhury S, et al. Eur J Cancer. 2008 Oct;44(15):2152-61. doi: 10.1016/j.ejca.2008.06.028. Epub 2008 Sep 29. Eur J Cancer. 2008. PMID: 18829302 Review.

6

Combination systemic therapy for advanced renal cell carcinoma.

Miller RE, Larkin JM. Miller RE, et al. Oncologist. 2009 Dec;14(12):1218-24. doi: 10.1634/theoncologist.2009-0105. Epub 2009 Nov 25. Oncologist. 2009. PMID: 19939892 Free article. Review.

7

A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.

Larkin JM, Ferguson TR, Pickering LM, Edmonds K, James MG, Thomas K, Banerji U, Berns B, de Boer C, Gore ME. Larkin JM, et al. Br J Cancer. 2010 Oct 12;103(8):1149-53. doi: 10.1038/sj.bjc.6605889. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842130 Free PMC article. Clinical Trial.

8

Sunitinib for metastatic renal cell carcinoma.

Mukherji D, Larkin J, Pickering L. Mukherji D, et al. Among authors: larkin j. Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94. Future Oncol. 2010. PMID: 20919823 Review.

9

Does axitinib (AG-01376) have a future role in metastatic renal cell carcinoma and other malignancies?

Goldstein R, Pickering L, Larkin J. Goldstein R, et al. Among authors: larkin j. Expert Rev Anticancer Ther. 2010 Oct;10(10):1545-57. doi: 10.1586/era.10.134. Expert Rev Anticancer Ther. 2010. PMID: 20942625 Review.

10

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.

Josephs D, Hutson TE, Cowey CL, Pickering LM, Larkin JM, Gore ME, Van Hemelrijck M, McDermott DF, Powles T, Chowdhury P, Karapetis C, Harper PG, Choueiri TK, Chowdhury S. Josephs D, et al. BJU Int. 2011 Oct;108(8):1279-83. doi: 10.1111/j.1464-410X.2010.09990.x. Epub 2011 Jan 18. BJU Int. 2011. PMID: 21244613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,283 results

Search Page

Filters